Liu J - Search Results

1

Identification and Analysis of Biomarkers Associated with Lipophagy and Therapeutic Agents for COVID-19.

Wu Y, Wu Z, Jin Q, Liu J, Xu P. Wu Y, et al. Among authors: liu j. Viruses. 2024 Jun 7;16(6):923. doi: 10.3390/v16060923. Viruses. 2024. PMID: 38932215 Free PMC article.

2

Polygalasaponin F treats mice with pneumonia induced by influenza virus.

Ye Y, Wang H, Liu J, Zhao F, Xu P. Ye Y, et al. Among authors: liu j. Inflammopharmacology. 2020 Feb;28(1):299-310. doi: 10.1007/s10787-019-00633-1. Epub 2019 Aug 24. Inflammopharmacology. 2020. PMID: 31446589 Free PMC article.

3

Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase.

Wang HX, Zeng MS, Ye Y, Liu JY, Xu PP. Wang HX, et al. Phytother Res. 2021 Jan;35(1):324-336. doi: 10.1002/ptr.6803. Epub 2020 Aug 5. Phytother Res. 2021. PMID: 32757226

4

A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).

Zeng MS, Yu WD, Wang HX, Liu JY, Xu PP. Zeng MS, et al. Int J Biol Macromol. 2021 Jul 31;183:2248-2261. doi: 10.1016/j.ijbiomac.2021.06.017. Epub 2021 Jun 7. Int J Biol Macromol. 2021. PMID: 34111482 Free PMC article.

5

Puerarin reduces impairment of intestinal and adipose immune responses to influenza virus infection in mice.

Zeng MS, Yu WD, Wang HX, Xu PP, Liu JY. Zeng MS, et al. Arch Virol. 2021 Sep;166(9):2387-2397. doi: 10.1007/s00705-021-05112-z. Epub 2021 Jun 10. Arch Virol. 2021. PMID: 34114139 Free PMC article.

6

Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice. Evidences of its mechanism of action.

Yu W, Zeng M, Xu P, Liu J, Wang H. Yu W, et al. Among authors: liu j. Phytomedicine. 2021 Nov;92:153724. doi: 10.1016/j.phymed.2021.153724. Epub 2021 Aug 21. Phytomedicine. 2021. PMID: 34509953

7

Geraniin as a potential inhibitor of SARS-CoV-2 3CL^pro.

Yu WD, Jin QY, Zeng MS, Liu JY, Xu PP. Yu WD, et al. Nat Prod Res. 2022 Dec;36(23):6060-6063. doi: 10.1080/14786419.2022.2043308. Epub 2022 Feb 24. Nat Prod Res. 2022. PMID: 35200071

8

Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19.

Jin Q, Li W, Yu W, Zeng M, Liu J, Xu P. Jin Q, et al. Among authors: liu j. Comput Biol Med. 2022 Nov;150:106134. doi: 10.1016/j.compbiomed.2022.106134. Epub 2022 Sep 22. Comput Biol Med. 2022. PMID: 36201886 Free PMC article.

9

Study on the activity and mechanism of herbal formula anti-infection powder (AIP) against influenza-virus-induced pneumonia through genetic susceptibility genes.

Feng W, Zhang Y, Wu Y, Wu Z, Liu J, Xu P. Feng W, et al. Among authors: liu j. J Ethnopharmacol. 2024 Oct 18;337(Pt 3):118959. doi: 10.1016/j.jep.2024.118959. Online ahead of print. J Ethnopharmacol. 2024. PMID: 39426575

10

Prim-O-glucosylcimifugin alleviates influenza virus-induced pneumonia in mice by inhibiting the TGF-β1/PI3KCD/MSK2/RELA signalling pathway.

Wu YJ, Feng WW, Wu ZL, Zhang YY, Liu JY, Xu PP. Wu YJ, et al. Arch Virol. 2024 Oct 29;169(11):232. doi: 10.1007/s00705-024-06158-5. Arch Virol. 2024. PMID: 39467851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143,360 results

Search Page

Filters